A carregar...
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
c-Myc is a transcription factor that is constitutively and aberrantly expressed in over 70% of human cancers. Its direct inhibition has been shown to trigger rapid tumor regression in mice with only mild and fully reversible side effects, suggesting this to be a viable therapeutic strategy. Here we...
Na minha lista:
| Publicado no: | Mol Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7780693/ https://ncbi.nlm.nih.gov/pubmed/33397405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-020-01291-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|